Related Experiment Video
Updated: Jun 5, 2026
12:40
Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Integrative Mapping of Regulatory Variation in African American Hepatocytes Using Colocalization and MPRA: Toward
Carolina Clark1, Guang Yang2, Cristina Alarcon1
1Northwestern University.
Research Square
|June 4, 2026
Summary
This study generated expression quantitative trait loci (eQTL) data from African American liver cells, revealing ancestry-specific gene regulation crucial for precision medicine. Findings improve understanding of drug metabolism and advance equitable healthcare.
Area of Science:
- Genomics
- Pharmacogenomics
- Precision Medicine
Background:
- Genomic datasets often lack diversity, particularly from individuals of African ancestry.
- This underrepresentation limits understanding of ancestry-specific gene regulation and its impact on precision medicine.
- Existing gaps hinder accurate gene regulatory modeling and equitable precision medicine delivery.
Purpose of the Study:
- To generate and analyze expression quantitative trait loci (eQTL) data from African American hepatocytes.
- To identify ancestry-specific regulatory variations in genes relevant to pharmacogenomics.
- To integrate eQTL data with public resources and functional assays to enhance understanding of hepatic gene regulation.
Main Methods:
- Generated a novel eQTL dataset from 75 primary human hepatocytes of African American donors.
- Performed cis-eQTL mapping to identify single nucleotide polymorphism-gene associations.
- Integrated generated data with public liver eQTL resources (GTEx, Broadaway) and massively parallel reporter assay (MPRA) data.
Main Results:
- Identified 31,606 cis-eQTLs, including variations in pharmacogenomic genes like CYP4F11, SLC47A1, SLC28A1, and GSTM3.
- Discovered 17,585 eQTLs specific to the African American hepatocyte dataset, including the F5 gene, indicating ancestry-specific regulation.
- Colocalization analysis revealed shared regulatory architecture with GTEx data, and MPRA supported the functional relevance of identified variants.
Conclusions:
- Integrated ancestry-specific eQTL mapping, colocalization, and functional assays improve identification of causal regulatory variants in hepatocytes.
- Expanding diverse population cohorts and incorporating tissue-specific functional assays are vital for understanding hepatic gene regulation.
- Findings advance the understanding of regulatory mechanisms in pharmacogenomic traits and promote precision medicine in admixed populations.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...